Through a retrospective review of cutaneous adverse events associated with semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide in the FDA Adverse Event Reporting System, it was found that the 5 most common cutaneous reactions associated with GLP-1 agonists were eczematous, pruritus, drug eruptions, hyperhidrosis, and alopecia
These include: Nausea Vomiting Diarrhoea Constipation Abdominal pain These side effects are typically mild to moderate, most common when starting the medication or increasing the dose, and often subside over time
Who Is a Good Candidate for Semaglutide GLP-1 Weight Loss Injections
This effervescent formula ensures better absorption of glutathione helping to neutralize free radicals detoxify the body and protect skin from environmental damage
While still costly, they could come in below injectable list prices, Williams said